Zusammenfassung
Hintergrund
Das inzidentell durch die transurethrale Resektion der Prostata (TURP) entdeckte Prostatakarzinom (PC) wird bezüglich der Tumorkontrolle kontrovers beurteilt. Wir evaluierten an einem großen Patientenkollektiv, ob die radikale Prostatektomie (RP) nach TURP empfohlen werden kann.
Material and Methode:
Von 1207 Patienten zur RP wurde bei n=52 (4,3%) die Diagnose durch die TURP gestellt. In einer retrospektiven Analyse haben wir die Morbidität, das histopathologische Ergebnis und die Tumorkontrolle des T1a/b-Karzinoms analysiert.
Ergebnisse
Die Anzahl der inzidentellen PC nahm über die Jahre ab. In 5,8% bei inzidentellem PC und 0,5% nach Biopsie war kein residueller Tumor nachweisbar (p<0,001). Die Morbidität war vergleichbar ±TURP mit Ausnahme der Operationszeit (206 vs. 188 min) und Katheterverweildauer (19,3 vs. 17,3 Tage). Das Ergebnis bezüglich Kontinenz war identisch. Die Tumorkontrolle ergab keine Unterschiede für Lokalrezidive und PSA-freies Überleben.
Schlussfolgerung
Das inzidentelle PC nimmt über die Jahre ab, es handelt sich aber in >90% um einen klinisch relevanten Tumor. Die TURP vor einer RP ist kein ungünstiger prognostischer Faktor und die Morbidität ist vergleichbar mit Patienten, die durch die Nadelbiopsie diagnostiziert wurden. Unsere Daten legen die Schlussfolgerung nahe, dass man Patienten mit inzidentellem PC die RP uneingeschränkt empfehlen sollte, sofern die Patienten Kandidaten für eine kurative Therapie darstellen.
Abstract
Introduction
There is controversy regarding tumor control of incidental prostate cancer (PC). We evaluated in a large cohort if we can recommend radical prostatectomy after TURP.
Material and method
In 52 (4.3%) from a total of 1207 patients undergoing radical prostatectomy the diagnosis had been made by TURP. In a retrospective analysis we evaluated morbidity, histopathological results, and tumor control of pT1a/b tumors.
Results
The number of incidentally detected PC decreased with time. In 5.8% in the TURP group and in 0.5% of the needle biopsy group, there was no residual tumor found (p<0.001). Morbidity was similar ± TURP with the exception of operation time (206 vs 188 min) and catheter duration (19.3 vs 17.3 days). Postoperative continence was identical. There was no difference in tumor control for local recurrence-free survival and PSA-free survival with and without TURP.
Conclusions
The rate of incidentally detected PC by TURP decreases over time, but in almost all cases we found clinically relevant cancer. TURP is not an adverse prognostic factor and morbidity is similar compared with patients who were diagnosed by needle biopsy. Our data confirm that we should recommend radical prostatectomy to patients who are candidates for further curative therapy.
Literatur
Hanks GE, Leibel S, Kramer S (1983) The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J Urol 129: 309–311
Sandler HM, Hanks GE (1988) Analysis of the possibility that transurethral resection promotes metastasis in prostate cancer. Cancer 62: 2622–2627
Nativ O, Bergstralh EJ, Boyle ET Jr, Zincke H (1991) Transurethral resection versus needle biopsy prior to radical prostatectomy for stage C prostate cancer. Influence on progression and survival. Urology 37: 22–27
Bass RB Jr, Barrett DM (1980) Radical retropubic prostatectomy after transurethral prostatic resection. J Urol 124: 495–497
Bandhauer K, Senn E (1988) Radical retropubic prostatectomy after transurethral prostatic resection. Eur Urol 15: 180–181
Levine ES, Cisek VJ, Mulvihill MN, Cohen EL (1986) Role of transurethral resection in dissemination of cancer of prostate. Urology 28: 179–183
Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sozen S, Gill H (1998) Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 160: 2412–2417
Larsen MP, Carter HB, Epstein JI (1991) Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease. J Urol 146: 1059–1063
Epstein JI, Walsh PC, Brendler CB (1994) Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). J Urol 152: 1721–1729
Ramon J, Rossignol G, Leandri P, Gautier JR (1994) Morbidity of radical retropubic prostatectomy following previous prostate resection. J Surg Oncol 55: 14–19
Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, Wolfert R, Carter HB (1998) Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 160: 2407–2411
Meacham RB, Scardino PT, Hoffman GS, Easley JD, Wilbanks JH, Carlton CE Jr (1989) The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J Urol 142: 320–325
Paulson DF, Cox EB (1987) Does transurethral resection of the prostate promote metastatic disease? J Urol 138: 90–91
Mansfield JT, Stephenson RA (1996) Does transurethral resection of the prostate compromise the radical treatment of prostate cancer? Semin Urol Oncol 14: 174–177
Duncan W, Catton CN, Warde P et al. (1994) The influence of transurethral resection of prostate on prognosis of patients with adenocarcinoma of the prostate treated by radical radiotherapy. Radiother Oncol 31: 41–50
Natarajan N, Mettlin C, Murphy GP, Schmidt J (1987) Pretreatment transurethral resection of prostate cancer and disease-free survival. Anticancer Res 7: 395–399
Fowler JE Jr, Fisher HA, Kaiser DL, Whitmore WF (1984) Relationship of pretreatment transurethral resection of the prostate to survival without distant metastases in patients treated with 125I-implantation for localized prostatic cancer. Cancer 53: 1857–1863
Kupelian PA, Elshaikh M, Reddy CA, Zippe C, Klein EA (2002) Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol 20: 3376–3385
Arcangeli G, Micheli A, Verna L et al. (1995) Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer. Radiother Oncol 35: 123–128
Seymore CH, el-Mahdi AM, Schellhammer PF (1986) The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys 12: 1597–1600
Elder JS, Gibbons RP, Correa RJ Jr, Brannen GE (1984) Morbidity of radical perineal prostatectomy following transurethral resection of the prostate. J Urol 132: 55–57
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paul, R., Knebel, C., van Randenborgh, H. et al. Inzidentelles Prostatakarzinom: Kann und soll die radikale Prostatektomie danach empfohlen werden?. Urologe 44, 1052–1058 (2005). https://doi.org/10.1007/s00120-005-0859-8
Issue Date:
DOI: https://doi.org/10.1007/s00120-005-0859-8